Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis
Reads0
Chats0
TLDR
Evidence suggests that high midlife TC increases risk of late-life AD, and may correlate with the onset of AD pathology, and significant gaps in the literature regarding TC and late- life dementia remain.Abstract:
This work was supported by NHMRC
Research Fellowship #1002560 for KJA, and NIHR
fellowship PDF-2012-05-197 for RP.read more
Citations
More filters
Journal ArticleDOI
2022 Alzheimer's disease facts and figures
TL;DR: The public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality and morbidity, use and costs of care, and the overall impact on family caregivers, the dementia workforce and society are described are described.
Journal ArticleDOI
Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study
Michaël Schwarzinger,Bruce G. Pollock,Bruce G. Pollock,Omer S. M. Hasan,Omer S. M. Hasan,Carole Dufouil,Jürgen Rehm,Sylvain Baillot,Quentin Guibert,Frédéric Planchet,Stéphane Luchini +10 more
TL;DR: Alcohol use disorders were a major risk factor for onset of all types of dementia, and especially early-onset dementia, so screening for heavy drinking should be part of regular medical care, with intervention or treatment being offered when necessary.
Journal ArticleDOI
Physical Activity and Sports-Real Health Benefits: A Review with Insight into the Public Health of Sweden
TL;DR: In conclusion, sports can be evolving, if personal capacities, social situation, and biological and psychological maturation are taken into account and evidence suggests a dose–response relationship such that being active, even to a modest level, is superior to being inactive or sedentary.
Journal ArticleDOI
The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms.
TL;DR: A narrative review aims to explain why there is still controversy over statin use and how both effects can, and may, be possible.
Journal ArticleDOI
Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
Raúl Loera-Valencia,Julen Goikolea,Cristina Parrado-Fernandez,Paula Merino-Serrais,Silvia Maioli +4 more
TL;DR: A broad perspective is given on the relationship between hypercholesterolemia and AD, cholesterol lowering therapies for AD patients and the role of oxysterols in pathological and non-pathological conditions, and proposes cholesterol metabolites as valuable targets for prevention and alternative AD treatments.
References
More filters
Journal ArticleDOI
Meta-Analysis in Clinical Trials*
TL;DR: This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.
Journal ArticleDOI
Quantifying heterogeneity in a meta‐analysis
TL;DR: It is concluded that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity, and one or both should be presented in publishedMeta-an analyses in preference to the test for heterogeneity.
Journal Article
Cochrane Handbook for Systematic Reviews of Interventions
Journal ArticleDOI
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher,Larissa Shamseer,Mike Clarke,Davina Ghersi,Alessandro Liberati,Mark Petticrew,Paul G. Shekelle,Lesley A. Stewart +7 more
TL;DR: A reporting guideline is described, the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols 2015 (PRISMA-P 2015), which consists of a 17-item checklist intended to facilitate the preparation and reporting of a robust protocol for the systematic review.
Ítems de referencia para publicar Protocolos de Revisiones Sistemáticas y Metaanálisis: Declaración PRISMA-P 2015 Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher,Larissa Shamseer,Michael Clarke,Davina Ghersi,Alessandro Liberati,Mark Petticrew,Lesley A. Stewart +6 more
Related Papers (5)
Dementia prevention, intervention, and care
Gill Livingston,Gill Livingston,Andrew Sommerlad,Vasiliki Orgeta,Sergi G. Costafreda,Sergi G. Costafreda,Jonathan Huntley,Jonathan Huntley,David Ames,Clive Ballard,Sube Banerjee,Alistair Burns,Jiska Cohen-Mansfield,Claudia Cooper,Claudia Cooper,Nick C. Fox,Laura N. Gitlin,Robert Howard,Robert Howard,Helen C. Kales,Eric B. Larson,Eric B. Larson,Karen Ritchie,Karen Ritchie,Kenneth Rockwood,Elizabeth L Sampson,Quincy M. Samus,Lon S. Schneider,Geir Selbæk,Geir Selbæk,Linda Teri,Naaheed Mukadam +31 more